144Filing Date: Aug 28, 2026

Edwards Lifesciences (EW)

Insider Proposed Sale Notice

View SEC Filing
ACC: 0001921094-26-000963

Sale Plan

Bruls Annette
Officer·Edwards Lifesciences
Proposed
CommonNYSE
Shares2.64K
Est. DateAug 28
Market Value$237.9K
BrokerCharles Schwab & Co., Inc.
AcquisitionRestricted Stock Lapse · EDWARDS LIFESCIENCES CORPORATION
Acquired DateMay 8, 2026
Amount Acquired733
% Outstanding0.0005%
Exercise / Payment Details
Paid: May 8, 2026Method: Equity Compensation
No sales in the past 3 months
Signature & Compliance expand_more
Notice DateAug 28, 2026
Signature Annette Bruls
Issuer Info expand_more
CompanyEdwards Lifesciences Corp
CIK0001099800
SEC File No.001-15525
Phone9492502500
AddressONE EDWARDS WAY, IRVINE, CA 92614

keid analysis is for reference only and does not constitute investment advice.